0B68 Baserga, Renato - Thomas Jefferson University - Thomas Jefferson University
rxb008

Renato L. Baserga, MD

Contact Dr. Baserga

Kimmel Cancer Center
233 S. Tenth Street, Suite 624 A
Philadelphia, PA 19107

(215) 503-4513
(215) 923-0249 fax

Most Recent Peer-reviewed Publications

  1. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth
  2. Growth of v-src-transformed cells in serum-free medium through the induction of growth factors
  3. The decline and fall of the IGF-I receptor
  4. Nutrient restriction and radiation therapy for cancer treatment: When less is more
  5. The type 1 insulin-like growth factor receptor and resistance to DACH1
  6. Expression of Micro-RNA-145 is regulated by a highly conserved genomic sequence 3' to the pre-miR
  7. Regulation of microRNA-145 by growth arrest and differentiation
  8. Mutual interaction and reciprocal down-regulation between c-met and insulin receptor substrate-1
  9. MicroRNA, cell cycle, and human breast cancer
  10. The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms
  11. Mechanism of growth inhibition by microRNA 145: The role of the IGF-I receptor signaling pathway
  12. Growth inhibition by microRNAs that target the insulin receptor substrate-1
  13. Customizing the targeting of IGF-1 receptor
  14. AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells
  15. The insulin receptor substrate-1: A biomarker for cancer?
  16. Regulation of insulin receptor substrate-1 expression levels by caveolin-1
  17. The role of insulin receptor substrate-1 in the oncogen 05A3 icity of simian virus 40 T antigen
  18. The role of insulin receptor substrate-1 in transformation by v-src
  19. Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes
  20. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells
0